Profile data is unavailable for this security.
About the company
Zhejiang Cheng Yi Pharmaceutical Co Ltd is a China-based company primarily engaged in the research, development, production and sale of active pharmaceutical ingredients and preparations. The Company operates through five segments. The Preparation segment is primarily engaged in production and sale of glucosamine hydrochloride preparations and ribavirin preparations. The Active Pharmaceutical Ingredient segment is primarily engaged in production and sale of gastrodin and azathioprine active pharmaceutical ingredients. The Intermediates and Others segment is primarily engaged in production and sale of pharmaceutical intermediates. The Traditional Chinese Medicine segment is primarily engaged in production and sale of traditional Chinese medicines. The Food segment is primarily engaged in production and sale of health foods.
- Revenue in CNY (TTM)790.86m
- Net income in CNY226.35m
- Incorporated2001
- Employees738.00
- LocationZhejiang Cheng Yi Pharmaceutical Co LtdNo. 118 Huagong Road, Dongtou DistrictSHANGHAI 201100ChinaCHN
- Phone+86 2 133283295
- Fax+86 2 133283305
- Websitehttps://www.chengyipharma.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beijing Kawin Technol Sha-hld Co Ltd | 1.15bn | 136.81m | 3.72bn | 600.00 | 27.58 | 2.03 | -- | 3.24 | 0.789 | 0.789 | 6.61 | 10.73 | 0.4166 | 1.52 | 2.64 | 1,910,937.00 | 5.26 | 5.55 | 7.12 | 7.14 | 81.89 | 84.98 | 12.64 | 9.40 | 2.55 | -- | 0.2017 | 45.97 | -12.87 | 8.32 | 22.18 | 21.60 | 40.30 | -- |
| Zhejiang Cheng Yi Pharmaceutical Co Ltd | 790.86m | 226.35m | 3.79bn | 738.00 | 16.55 | 2.87 | -- | 4.79 | 0.6997 | 0.6997 | 2.46 | 4.04 | 0.4508 | 1.95 | 20.88 | -- | 13.02 | 11.48 | 15.87 | 14.03 | 68.99 | 69.02 | 28.88 | 24.63 | 0.985 | -- | 0.0808 | 37.22 | 6.36 | 0.9546 | 23.21 | 8.84 | -20.09 | 11.39 |
| Henan Taloph Pharmaceutical Stock Co Ltd | 1.79bn | 46.95m | 3.83bn | 2.21k | 75.58 | 2.41 | -- | 2.14 | 0.0884 | 0.0884 | 3.31 | 2.78 | 0.4791 | 2.74 | 1.60 | 807,429.60 | 1.45 | 0.3241 | 3.13 | 0.6105 | 23.45 | 26.22 | 3.02 | 0.6331 | 0.9038 | 1.86 | 0.3592 | 52.82 | -6.21 | 8.16 | 16.00 | 2.61 | -19.14 | -- |
| Shanghai Shen Lian Biomedical Corp | 292.81m | -30.34m | 3.97bn | 391.00 | -- | 2.81 | -- | 13.55 | -0.0739 | -0.0739 | 0.713 | 3.43 | 0.1864 | 1.42 | 0.9144 | 748,865.90 | -2.21 | 3.53 | -2.40 | 3.80 | 57.36 | 73.49 | -11.87 | 16.93 | 3.64 | -- | 0.0106 | 43.52 | 0.6394 | 3.63 | -241.95 | -- | -3.99 | -- |
| Holder | Shares | % Held |
|---|---|---|
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2025 | 2.85m | 0.87% |
| HuaAn Fund Management Co., Ltd.as of 30 Jun 2025 | 1.69m | 0.52% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 918.18k | 0.28% |
| CITIC-Prudential Fund Management Co., Ltd.as of 30 Jun 2025 | 791.70k | 0.24% |
| Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2025 | 265.10k | 0.08% |
| CCB Principal Asset Management Co., Ltd.as of 30 Jun 2025 | 253.30k | 0.08% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2025 | 250.10k | 0.08% |
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2025 | 197.10k | 0.06% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 167.14k | 0.05% |
| New China Fund Management Co., Ltd.as of 30 Jun 2025 | 159.00k | 0.05% |
